Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck estimated Intangible Amortization — Year 1 ($M) ($M)
Form 10-K Note 8
Latest, FY2025
3,800
Period ended Dec 31, 2025
Change on a year earlier
+58.3%
2,400 in FY2024
History
10 years
Since FY2016
Sources
10
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Estimated Intangible Amortization — Year 1 ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,800 | +58.3% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 2,400 | +33.3% | Form 10-K (filed 2025-02-25) ↗ |
| FY2023 | Dec 31, 2023 | 1,800 | 0.0% | Form 10-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 1,800 | +5.9% | Form 10-K (filed 2023-02-24) ↗ |
| FY2021 | Dec 31, 2021 | 1,700 | +13.3% | Form 10-K (filed 2022-02-25) ↗ |
| FY2020 | Dec 31, 2020 | 1,500 | -6.2% | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 1,600 | +6.7% | Form 10-K (filed 2020-02-26) ↗ |
| FY2018 | Dec 31, 2018 | 1,500 | -46.4% | Form 10-K (filed 2019-02-27) ↗ |
| FY2017 | Dec 31, 2017 | 2,800 | -12.5% | Form 10-K (filed 2018-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 3,200 | – | SEC Filing ↗ |
Cite this data
StockData. (2026). Merck Estimated Intangible Amortization — Year 1 ($M) ($M), annual FY2016–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/intang_est_y1
See every metric in the Merck KPI table. Data updated Oct 26, 2026.